Two generic drug makers will pay Pfizer and Takeda Pharmaceutical $2.15 billion for producing generic versions of a heartburn drug before its patent expired. More
-
Sponsored By:
-
Sponsored By:
-
Sponsored By:
PFE
Recent Articles
15 Dividend Stocks to Buy on the Cheap
Here are 15 dividend stocks that I find a great value today based on our fundamental analysis. All provide great yields and solid growth potential More
Pharma, Tech Drive the Dow: Monday’s IP Market Recap
markets managed to start out the new month on a up note, as pharmaceuticals and technology companies shined during a broad-based rally More
Johnson & Johnson Is One Must Own Dividend Stock
Johnson & Johnson has delivered steady dividend increases for the last 50 years, a track record that makes it a stalwart for dividend portfolios More
Options Volume: Pfizer (PFE) Calls Increase
Increased call options volume can be a sign of continued strength or a jump to come. More
Int’l Worries Weigh on Wall Street — Wednesday’s IP Market Recap
Lower growth projections in China and Europe gave investors pause Wednesday, a particularly ugly day for blue-chip consumer staples. More
4 Large-Cap Funds for Continued Upside
If the bulls are right, these four large-cap funds should cash in. Plus, they offer protection in case the bulls happen to be wrong. More
